Related Experiment Video
Updated: Jun 22, 2026

09:37
Cellular Encapsulation in 3D Hydrogels for Tissue Engineering
Published on: October 26, 2009
Cell-responsive hydrogel for encapsulation of vascular cells
Thomas P Kraehenbuehl1, Lino S Ferreira, Prisca Zammaretti
1Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Biomaterials
|June 9, 2009
Summary
This study explores a new hydrogel for tissue regeneration. The matrix metalloproteinase (MMP)-responsive hydrogel co-encapsulates vascular cells and thymosin beta4 (Tbeta4), promoting cell survival and vascular network formation for potential ischemic tissue repair.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Vascular Biology
Background:
- Developing advanced biomaterials for tissue regeneration is crucial.
- Poly(ethylene glycol) (PEG)-based hydrogels offer tunable properties for cell encapsulation.
- Matrix metalloproteinases (MMPs) play key roles in tissue remodeling and can be leveraged for controlled release systems.
Purpose of the Study:
- To investigate the potential of a synthetic MMP-responsive PEG-hydrogel as a bioactive co-encapsulation system.
- To evaluate the hydrogel's ability to support vascular cells and deliver thymosin beta4 (Tbeta4).
- To assess the hydrogel's efficacy in promoting vascularization and tissue regeneration in vitro.
Main Methods:
- Synthesized a matrix metalloproteinase (MMP)-responsive poly(ethylene glycol) (PEG)-based hydrogel.
- Co-encapsulated human umbilical vein endothelial cells (HUVECs) and thymosin beta4 (Tbeta4) within the hydrogel.
- Assessed HUVEC adhesion, survival, migration, gene expression, and vascular network formation in vitro.
Main Results:
- The hydrogel created a 3D environment supporting HUVEC adhesion, survival, and migration.
- Tbeta4 incorporation enhanced HUVEC survival and upregulated specific endothelial genes (VE-cadherin, angiopoietin-2) while downregulating others (von Willebrand factor).
- Encapsulated HUVECs secreted increased levels of MMP-2 and MMP-9, triggering controlled Tbeta4 release and facilitating vascular-like network formation.
Conclusions:
- MMP-responsive PEG-hydrogels serve as effective bioactive co-encapsulation systems for vascular cells and Tbeta4.
- This system promotes vascularization and offers potential for in situ regeneration of ischemic tissues.
- The hydrogel's controlled release mechanism, triggered by MMPs, enhances its therapeutic potential.

